Retatrutide

60mg≥99.5% Purity

Maximum-dosage retatrutide lyophilised powder for intensive clinical protocols.

Request a Quote

Pricing available for qualified medical professionals, clinics, and distributors.

Enquire Now Download Monograph View FAQ

Mechanism of Action

Retatrutide is a triple agonist targeting GIP, GLP-1, and glucagon receptors.

Read the research

Clinical Benefits

Triple receptor agonist mechanism
Maximum available dosage
For intensive clinical protocols
Pharmaceutical-grade quality assurance

Specifications

MechanismTriple agonist (GIP/GLP-1/Glucagon)

Purity≥99.5%

Dosage60mg per vial

Storage & Handling

Store at 2–8°C
Protect from light

Related Products

Lyophilised Powder

Retatrutide

30mg

Lyophilised Powder

Tirzepatide

50mg

For professional medical use only. Not for retail sale to the general public. Pricing available on request for qualified medical institutions and distributors.